900174-06-3

Upstream product

• 900174-05-2 2-ethoxy-4-iodo-1-isopropoxybenzene 

Downstream Products

• 918810-84-1 2-(4-((tert-butoxycarbonyl)methyl)phenylamino)-2-(3-ethoxy-4-isopropoxyphenyl)acetic acid 
• 1610784-51-4 C₄₀H₅₀N₄O₇ 
• 1520082-82-9 C₄₃H₅₅N₅O₁₀S 
• 1520082-81-8 C₄₁H₅₂N₄O₉S 
• 1520082-80-7 C₄₂H₅₄N₄O₉S 
• 1520082-79-4 C₄₂H₅₂N₄O₉S 
• 1520082-78-3 C₄₂H₅₃N₅O₈ 
• 1520082-77-2 C₃₉H₄₉N₅O₇ 
• 1520082-76-1 C₃₉H₄₈N₄O₈ 
• 1520082-75-0 C₄₁H₅₁N₅O₉ 
• 1520082-74-9 C₃₉H₄₉N₅O₉S 
• 1520082-73-8 C₃₉H₅₀N₆O₉S 
• 1520082-71-6 C₃₉H₄₈N₄O₇ 
• 745830-47-1 2-((1-aminoisoquinolin-6-yl)amino)-N-benzyl-2-(3-ethoxy-4-isopropoxyphenyl)acetamide trifluoroacetic acid salt 

Relevant academic research and scientific papers

Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants

The present invention provides novel phenylglycinamide derivatives of Formula (I) or (IV): or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein the variables W, W1, Y, Z, R7, R8, R9, and R11 are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.

PHENYLGLYCINAMIDE DERIVATIVES USEFUL AS ANTICOAGULANTS

The present invention relates generally to phenylglycinamide derivatives that inhibit serine proteases. In particular it is directed to novel phenylglycinamide derivatives, and analogues thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.